Industry observations highlight shifting traveler behavior, reduced booking activity, and increased focus on privacy ...
The Trump administration doesn't plan to reclassify the drug for medical use at this time — it will remain a Schedule I drug.
The new Mismaloya pier is an exciting attraction, but worrying data from the airport suggests trouble in paradise.